本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Silence Therapeutics Plc

5.15
-0.1000-1.90%
盘后5.200.0500+0.97%18:45 EDT
成交量:45.96万
成交额:243.68万
市值:2.43亿
市盈率:-3.07
高:5.83
开:5.32
低:5.00
收:5.25
52周最高:20.48
52周最低:1.97
股本:4,723.39万
流通股本:2,491.57万
量比:9.84
换手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):-1.6767
每股收益(LYR):-0.9796
净资产收益率:-66.96%
总资产收益率:-22.25%
市净率:2.58
市盈率(LYR):-5.26

数据加载中...

2025/08/14

重要事件披露

Form 8-K - Current report
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/06/27

重要事件披露

Form 8-K - Current report
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/06

重要事件披露

Form 8-K - Current report
2025/05/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/02

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/05/11

SEC问询函

Form CORRESP - Correspondence
2024/03/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/13

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]